Skip to main content
FinSpry Logo
FinSpry
NRXP logo
NRXP
(NASDAQ)
NRx Pharmaceuticals, Inc.
$2.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NRx Pharmaceuticals (NRXP) Stock Price & Financial Analysis

NRx Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.12 - $2.24
52-Week High$3.84
52-Week Low$1.58
Open$2.13
Volume354.96K
Average Volume (3M)354.96K
Market Cap48.91M
Shares Outstanding22.23M
Price to Sales (P/S)198.43
EV/EBITDA-1.34
Revenue (TTM)242.00K
Net Income (TTM)-38.06M
EPS (TTM)$-1.71
Profit Margin-15727.69%
Operating Margin-5757.44%
50-Day MA$1.96
200-Day MA$2.57
52-Week Change11.34%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NRx Pharmaceuticals

What is the current stock price for NRXP?

As of the latest trading session, NRXP stock trades at $2.20. The 52-week range is $1.58–$3.84, with a day range of $2.12–$2.23.

What is the P/E ratio for NRXP?

The P/E ratio (Price-to-Earnings) for NRXP is shown in the Key Statistics section. This valuation metric helps compare NRx Pharmaceuticals, Inc. to industry peers.

Does NRXP pay dividends?

NRx Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NRXP?

Based on 3 analysts, the consensus for NRXP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NRXP?

NRx Pharmaceuticals's market capitalization is $48.9M, classifying it as a micro-cap company. NRx Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.